Today: 7 February 2026
Subscribe
Browse Category

Investment Analysis News 14 December 2025

NuScale Power Stock (NYSE: SMR) News, Forecasts and Analysis for Dec. 14, 2025: What’s Driving the Volatility?

NuScale Power Stock (NYSE: SMR) News, Forecasts and Analysis for Dec. 14, 2025: What’s Driving the Volatility?

NuScale Power Corporation (NYSE: SMR) has become one of the most closely watched “advanced nuclear” stocks in 2025—and one of the most volatile. As of Sunday, December 14, 2025, U.S. markets are closed, with SMR last settling at $18.34 on Friday, Dec. 12, after a sharp -13.57% one-day drop on heavy trading volume. StockAnalysis What investors are reacting to right now is less about a single headline and more about a stack of catalysts and cross-currents: a looming shareholder vote that could double authorized shares, ongoing concerns about dilution and capital needs, a major shareholder’s planned stake monetization, and a
14 December 2025
·····
Fluence Energy (FLNC) Stock News, Forecasts and Analyst Outlook — What Investors Are Watching on December 14, 2025

Fluence Energy (FLNC) Stock News, Forecasts and Analyst Outlook — What Investors Are Watching on December 14, 2025

Fluence Energy (NASDAQ: FLNC) is in focus after fresh institutional buying headlines, a major UK battery storage milestone, and sharply divided analyst price targets. Here’s what’s driving the stock on Dec. 14, 2025. December 14, 2025 — Fluence Energy, Inc. (NASDAQ: FLNC) is drawing renewed attention from investors this weekend as a cluster of developments reshapes the near-term narrative: a newly disclosed institutional position, ongoing debate over the stock’s valuation after a volatile move in recent sessions, and a drumbeat of project wins that reinforce Fluence’s role in grid-scale battery storage. MarketBeat With U.S. markets closed on Sunday, the latest
14 December 2025
·····
Arcus Biosciences (RCUS) Stock News, Forecasts and Analyst Targets — Dec. 14, 2025 Update

Arcus Biosciences (RCUS) Stock News, Forecasts and Analyst Targets — Dec. 14, 2025 Update

Arcus Biosciences, Inc. (NYSE: RCUS) is ending the weekend under a bright—and volatile—spotlight after a major clinical-program reset triggered a sharp Friday selloff. As of Sunday, December 14, 2025, the last reported close was $21.53, down 14.36% from the prior session, reflecting investor repricing after Arcus and partner Gilead halted a pivotal upper-GI cancer study. StockAnalysis What comes next for Arcus Biosciences stock now hinges less on TIGIT in gastric cancer and more on whether casdatifan can become a durable “anchor” asset in kidney cancer—and whether Arcus’ early move into inflammation and immunology can add long-dated upside without burning credibility
14 December 2025
····
Sandisk (SNDK) Stock News Today: Downgrade Sparks Sharp Selloff, Analyst Price Targets, and 2026 Outlook (Dec. 14, 2025)

Sandisk (SNDK) Stock News Today: Downgrade Sparks Sharp Selloff, Analyst Price Targets, and 2026 Outlook (Dec. 14, 2025)

Published: Sunday, Dec. 14, 2025 (U.S. markets closed) Sandisk Corporation stock (NASDAQ: SNDK) heads into the Monday, Dec. 15 open with investors still digesting one of the biggest single-day drops among large-cap tech names this month—an abrupt reversal after a year defined by AI-driven enthusiasm, index inclusion, and a powerful memory-cycle rebound. Below is a complete, publication-ready roundup of today’s key headlines and context (Dec. 14, 2025), plus the latest analyst forecasts, price targets, and what to watch next. Sandisk stock price today: where SNDK stands on Dec. 14, 2025 Because today is Sunday, there is no regular-session trading in
14 December 2025
····
Oklo Inc. Stock (NYSE: OKLO) News, Forecasts and Analyst Outlook on Dec. 14, 2025 — ATM Offering, Sector Selloff, and What Investors Are Watching

Oklo Inc. Stock (NYSE: OKLO) News, Forecasts and Analyst Outlook on Dec. 14, 2025 — ATM Offering, Sector Selloff, and What Investors Are Watching

Updated: December 14, 2025 Oklo Inc. (NYSE: OKLO) is ending the week at the center of a familiar high-volatility trade: advanced nuclear power as a potential solution for AI-era electricity demand—and the equally familiar pushback investors deliver when dilution risk rises. As of the last U.S. market close (Friday, Dec. 12, 2025), Oklo shares finished at $87.42, down 15.13% on the day, following a sharp weekly slide that market commentary tied to weakness across uranium and nuclear-linked stocks. StockAnalysis+1 Below is a detailed, publication-ready breakdown of today’s most relevant Oklo stock news, current forecasts, and the leading analyst narratives shaping
14 December 2025
·····
RH Stock News & Forecast (NYSE:RH) on Dec. 14, 2025: Q3 FY2025 Earnings, Guidance Reset, and New Analyst Price Targets

RH Stock News & Forecast (NYSE:RH) on Dec. 14, 2025: Q3 FY2025 Earnings, Guidance Reset, and New Analyst Price Targets

Published: Sunday, December 14, 2025 (U.S. markets last closed Friday, Dec. 12) RH (NYSE:RH)—the luxury home furnishings and lifestyle retailer—heads into the new week with investors digesting a busy stretch of catalysts: a fresh quarterly report, updated full‑year outlook, and a wave of analyst target changes that reshaped the near‑term narrative around tariffs, margin pressure, and a still‑sluggish housing backdrop. Reuters+1 On Friday, RH shares closed at $162.01, up roughly 5.7% on the day after the company’s results and outlook reset hit the tape late Thursday. StockAnalysis RH stock today: what changed heading into Dec. 14, 2025? The immediate catalyst
14 December 2025
·····
Amicus Therapeutics (FOLD) Stock News, Forecasts and Analyst Outlook on Dec. 14, 2025: What’s Driving the Rally?

Amicus Therapeutics (FOLD) Stock News, Forecasts and Analyst Outlook on Dec. 14, 2025: What’s Driving the Rally?

Amicus Therapeutics (NASDAQ: FOLD) is near a 52-week high after strong results and bullish analyst coverage. Here’s the latest news, forecasts, catalysts, and key risks as of Dec. 14, 2025. As of Sunday, December 14, 2025 (with U.S. markets closed), Amicus Therapeutics, Inc. (NASDAQ: FOLD) is finishing the week in the spotlight after a sharp move higher. The stock last traded around $10.55 on Friday, December 12, after climbing roughly 6.6% on the session and touching an intraday high of $10.85—a level that also marks the top end of its $5.51–$10.85 52‑week range. Yahoo Finance The late-week push has also
14 December 2025
····
lululemon athletica (LULU) Stock News Today (Dec. 14, 2025): CEO Transition, Q3 Beat, Buyback Boost, and Nasdaq-100 Exit in Focus

lululemon athletica (LULU) Stock News Today (Dec. 14, 2025): CEO Transition, Q3 Beat, Buyback Boost, and Nasdaq-100 Exit in Focus

Lululemon (NASDAQ: LULU) stock is back in the spotlight after a Q3 earnings beat, updated fiscal 2025 guidance, a $1.0B buyback authorization increase, a CEO succession announcement, and confirmation it will be removed from the Nasdaq-100. Here’s what investors are watching as of December 14, 2025. lululemon athletica inc. stock (NASDAQ: LULU) has become one of the most talked-about retail names heading into the final stretch of 2025. The story is no longer just about athleisure demand—it’s about a leadership reset, a turnaround effort in the Americas, and index-related catalysts that could influence trading flows before year-end. Because December 14,
14 December 2025
····
Rivian Stock (RIVN) News, Forecasts and Analysis on Dec. 14, 2025: Autonomy & AI Day, Analyst Upgrades, and What Investors Should Watch Next

Rivian Stock (RIVN) News, Forecasts and Analysis on Dec. 14, 2025: Autonomy & AI Day, Analyst Upgrades, and What Investors Should Watch Next

Rivian Automotive, Inc. (NASDAQ: RIVN) is ending the week at the center of one of the EV market’s biggest storylines: a sharp stock swing tied to its first Autonomy & AI Day, new in-house self-driving silicon, and a push toward subscription software revenue. As of Sunday, December 14, 2025 (with U.S. markets closed for the weekend), Rivian shares last closed Friday, Dec. 12 at about $18.42, up roughly 12% on the day after a volatile two-session reaction to the company’s autonomy announcements. MarketBeat+2StockAnalysis+2 Below is a detailed, publication-ready breakdown of today’s Rivian stock news, the latest Wall Street forecasts, and
14 December 2025
·····
Clear Secure (YOU) Stock News on Dec. 14, 2025: CMS Medicare.gov Deal, JPMorgan Upgrade, Insider-Sale Filing, and Updated Price Targets

Clear Secure (YOU) Stock News on Dec. 14, 2025: CMS Medicare.gov Deal, JPMorgan Upgrade, Insider-Sale Filing, and Updated Price Targets

As of Sunday, December 14, 2025, Clear Secure, Inc. (NYSE: YOU) is one of the most talked-about mid-cap “digital identity” names after a sharp rally that pushed the stock to fresh multi-year highs in the last trading session. The move has been fueled by a major U.S. government-related healthcare contract, a bullish JPMorgan analyst upgrade, and renewed debate about whether Clear is transitioning from a travel-adjacent membership business into a broader, reusable identity platform for highly regulated industries. Clear Secure, Inc. Below is a complete, publication-ready rundown of the latest Clear Secure stock news, forecasts, and analyses available as of
14 December 2025
·····
Pfizer Stock (PFE) News and Forecast for Dec. 14, 2025: Dividend, Obesity Deal, Oncology Catalysts, and What Analysts Expect Next

Pfizer Stock (PFE) News and Forecast for Dec. 14, 2025: Dividend, Obesity Deal, Oncology Catalysts, and What Analysts Expect Next

Updated: Sunday, December 14, 2025 (U.S. markets last closed Friday, Dec. 12) Pfizer Inc. (NYSE: PFE) is ending the week in a familiar spot—trading in the mid‑$20s—while investors weigh a high dividend payout against a fast-moving set of catalysts: new oncology data from the Seagen portfolio, a fresh attempt at an oral obesity drug, ongoing cost-cutting, and a looming shift in the U.S. COVID vaccine policy backdrop. Reuters+3StockAnalysis+3Reuters+3 Below is a detailed roundup of the most important Pfizer stock headlines, forecasts, and analyst takes available as of Dec. 14, 2025, plus what to watch next heading into Pfizer’s scheduled 2026
14 December 2025
····
Broadcom Stock (AVGO) News and Forecasts on Dec. 14, 2025: AI Revenue Surge Meets Margin Pressure and “Mystery Customer” Questions

Broadcom Stock (AVGO) News and Forecasts on Dec. 14, 2025: AI Revenue Surge Meets Margin Pressure and “Mystery Customer” Questions

Updated: December 14, 2025 (Sunday) — Broadcom Inc. (NASDAQ: AVGO) is heading into the new week under a spotlight after a sharp post-earnings selloff rattled the AI hardware trade. The pullback isn’t about demand—Broadcom just posted record results, raised its dividend again, and guided higher for the next quarter. Instead, investors are grappling with a more nuanced question: how profitable will Broadcom’s booming AI business be as custom chips and full rack-level systems become a larger slice of revenue? PR Newswire+2Reuters+2 What makes this moment especially notable for Broadcom stock is the contrast between strong top-line momentum and near-term margin
14 December 2025
····
1 … 161 162 163 164 165 … 282

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
Go toTop